Maravai LifeSciences Announces November 2024 Investor Conference Schedule
Rhea-AI Summary
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has announced its participation in two major investor conferences in November 2024. The company's executives will participate in fireside chats at the Stifel Healthcare Conference in New York on November 19 and the Jefferies Healthcare Conference in London on November 21. Both presentations will be available via live webcast on the company's Investor Relations website, with archived versions accessible after the events.
Positive
- None.
Negative
- None.
News Market Reaction – MRVI
On the day this news was published, MRVI declined 1.38%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in November.
On November 19, 2024, at 8:30 a.m. PST/ 11:30 a.m. EST, Kevin Herde, Chief Financial Officer, and Drew Burch, President, Nucleic Acid Production, will participate in a fireside chat at the Stifel Healthcare Conference in New York, NY.
On November 21, 2024, at 2:00 a.m. PST/ 9:00 a.m. GMT, Trey Martin, Chief Executive Officer, and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in London, England.
A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit www.maravai.com.
FAQ
When is Maravai LifeSciences (MRVI) presenting at the Stifel Healthcare Conference in November 2024?
When is Maravai LifeSciences (MRVI) presenting at the Jefferies Healthcare Conference in November 2024?
Where can I watch Maravai LifeSciences (MRVI) November 2024 investor conference presentations?
